<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03112330</url>
  </required_header>
  <id_info>
    <org_study_id>CMCENT-01</org_study_id>
    <nct_id>NCT03112330</nct_id>
  </id_info>
  <brief_title>A Clinical Study to Evaluate the Safety and Efficacy of Platelet Rich Plasma Injection for Atrophic Rhinitis</brief_title>
  <acronym>ARPRP</acronym>
  <official_title>A Single-center, Non-randomized, Open, Single-arm Confirmatory Clinical Study to Evaluate the Safety and Efficacy of Platelet Rich Plasma Injection for Patients With Atrophic Rhinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul St. Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul St. Mary's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the suggested research is to develop a treatment option using platelet rich
      plasma injection for regeneration of atropic nasal mucosa.

      Specific aims of the suggested research is to (1) access the effect of platelet rich plasma
      in the patients with atropic rhinitis . Moreover, we will (2) compare the conservative
      treatments including saline nasal irrigation or saline nasal spray.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical trials of platelet rich plasma injection for regeneration of atropic nasal mucosa.

        -  Injection interval and follow-up duration

             -  Injection interval 2 weeks (upto total 3 consecutive injection)

             -  Follow-up duration: 6 months

        -  Observation items, clinical assessment items and evaluation method

             -  Access the nasal mucosal status using nasal speculum.

             -  Access the nasal mucociliary function using saccharin test (primary outcome; once
                per month).

             -  Fill in the nasal symptom scores using Nasal Obstruction Symptom Evaluation(NOSE)
                Instrument, Sino-Nasal outcome Test 20, and Visual analog scale (secondary outcome;
                once per month)

        -  The other atrophic rhinitis patients who did not want to perform platelet rich plasma
           injection

             -  Random allocation to saline nasal irrigation or saline nasal spray group

             -  Perform same observation items, clinical assessment items and evaluation method as
                well as platelet rich plasma injection group
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 8, 2017</start_date>
  <completion_date type="Anticipated">April 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of mucociliary clearance function using the saccharin test</measure>
    <time_frame>2, 4, 8, 12, and 24th week</time_frame>
    <description>The change in saccharin test time of the 2, 4, 8, 12, and 24th week after first treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change of nasal symptoms using the Nasal Obstruction Symptom Evaluation(NOSE) Instrument</measure>
    <time_frame>2, 4, 8, 12, and 24th week</time_frame>
    <description>The change in NOSE total scores of the 2, 4, 8, 12, and 24th week after first treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of nasal symptoms using the Sino-Nasal outcome Test 20</measure>
    <time_frame>2, 4, 8, 12, and 24th week</time_frame>
    <description>The change in Sino-Nasal outcome Test 20 scores of the 2, 4, 8, 12, and 24th week after first treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of nasal symptoms using the Visual analog scale</measure>
    <time_frame>2, 4, 8, 12, and 24th week</time_frame>
    <description>The change in Visual analog scale scores of the 2, 4, 8, 12, and 24th week after first treatment</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Atrophic Rhinitis</condition>
  <arm_group>
    <arm_group_label>platelet rich plasma injection group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To evaluate the safety and efficacy of plasma rich platelet injection on inferior turbinate mucosa in patients with atrophic rhinitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Plasma rich platelet injection</intervention_name>
    <description>Plasma rich platelet injection with 26-gauge needle and 2cc syringe on inferior turbinate mucosa</description>
    <arm_group_label>platelet rich plasma injection group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Saline nasal spray</intervention_name>
    <description>two puffs of isotonic saline nasal spray twice daily</description>
    <arm_group_label>platelet rich plasma injection group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (&gt;18 years)

          -  Complaint of atrophic rhinitis symptoms including nasal crusting, nasal burning
             sensation, and postnasal drip

          -  Atrophic rhinitis view on nasal endoscopic finding

          -  Patients who informed sufficient about other atrophic rhinitis treatment options
             including Young's operation, lubricants, or saline irrigation, but, want more other
             active treatment option.

        Exclusion Criteria:

          -  Platelet related disorders

          -  Low serum platelet (&lt;100,000/㎕)

          -  Other hematologic disorders

          -  Septicemia

          -  Take anticoagulant drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sung Won Kim, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Do Hyun Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sung Won Kim, MD, PhD</last_name>
    <phone>82-2-2258-6216</phone>
    <email>kswent@catholic.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Do Hyun Kim, MD, PhD</last_name>
    <phone>82-2-2258-6318</phone>
    <email>dohyuni9292@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung Won Kim, MD, PhD</last_name>
      <phone>+820222586216</phone>
      <email>kswent@catholic.ac.ke</email>
    </contact>
    <contact_backup>
      <last_name>Do Hyun Kim, MD, PhD</last_name>
      <phone>+820222586112</phone>
      <email>dohyuni9292@naver.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Friji MT, Gopalakrishnan S, Verma SK, Parida PK, Mohapatra DP. New regenerative approach to atrophic rhinitis using autologous lipoaspirate transfer and platelet-rich plasma in five patients: Our Experience. Clin Otolaryngol. 2014 Oct;39(5):289-92. doi: 10.1111/coa.12269.</citation>
    <PMID>24938860</PMID>
  </reference>
  <reference>
    <citation>Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004 Apr;62(4):489-96. Review.</citation>
    <PMID>15085519</PMID>
  </reference>
  <reference>
    <citation>Hildenbrand T, Weber RK, Brehmer D. Rhinitis sicca, dry nose and atrophic rhinitis: a review of the literature. Eur Arch Otorhinolaryngol. 2011 Jan;268(1):17-26. doi: 10.1007/s00405-010-1391-z. Epub 2010 Sep 29. Review.</citation>
    <PMID>20878413</PMID>
  </reference>
  <reference>
    <citation>Mishra A, Kawatra R, Gola M. Interventions for atrophic rhinitis. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008280. doi: 10.1002/14651858.CD008280.pub2. Review.</citation>
    <PMID>22336840</PMID>
  </reference>
  <reference>
    <citation>Jaswal A, Jana AK, Sikder B, Nandi TK, Sadhukhan SK, Das A. Novel treatment of atrophic rhinitis: early results. Eur Arch Otorhinolaryngol. 2008 Oct;265(10):1211-7. doi: 10.1007/s00405-008-0629-5. Epub 2008 Mar 4.</citation>
    <PMID>18317788</PMID>
  </reference>
  <reference>
    <citation>Modrzyński M. Hyaluronic acid gel in the treatment of empty nose syndrome. Am J Rhinol Allergy. 2011 Mar-Apr;25(2):103-6. doi: 10.2500/ajra.2011.25.3577.</citation>
    <PMID>21679513</PMID>
  </reference>
  <reference>
    <citation>Canciani M, Barlocco EG, Mastella G, de Santi MM, Gardi C, Lungarella G. The saccharin method for testing mucociliary function in patients suspected of having primary ciliary dyskinesia. Pediatr Pulmonol. 1988;5(4):210-4.</citation>
    <PMID>3237448</PMID>
  </reference>
  <reference>
    <citation>Stavrakas M, Karkos PD, Markou K, Grigoriadis N. Platelet-rich plasma in otolaryngology. J Laryngol Otol. 2016 Dec;130(12):1098-1102. Review.</citation>
    <PMID>27938467</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>October 8, 2017</last_update_submitted>
  <last_update_submitted_qc>October 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul St. Mary's Hospital</investigator_affiliation>
    <investigator_full_name>Sung Won Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>atrophic rhinitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Rhinitis, Atrophic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

